Infectious Diseases News and Research

RSS

Moderate coffee consumption linked to lower risk of multiple cardiometabolic diseases

Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease and stroke, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

17 Sep 2024

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis.

From MicrosensDx 17 Sep 2024

NIH funds new research to combat emerging viruses

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID's new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.

14 Sep 2024

New research network focuses on high-priority viruses

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by these pathogens have no available vaccines or therapeutics, and investing in this research is key to preparing for potential public health crises - both in the United States and around the world. NIH's National Institute of Allergy and Infectious Diseases (NIAID) expects to commit approximately $100 million per year to fund the program, pending the availability of funds.

14 Sep 2024

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in-class small molecule WRN inhibitor targeting advanced metastatic microsatellite instability (MSI) cancers guided by synthetic lethality strategy.

13 Sep 2024

Researchers find no evidence of monkeypox infection in pets, despite presence of viral DNA

Study found that MPXV DNA on pets in mpox-affected households was likely due to human contamination, not true infection, as no live virus or antibodies were detected.

12 Sep 2024

COVID-19 vaccines prevented millions of deaths across Latin America and the Caribbean, study shows

Researchers estimate that COVID-19 vaccines averted between 610,000 and 2.62 million deaths in select Latin American and Caribbean countries from early 2021 to May 2022.

12 Sep 2024

New vaccine candidate shows promise for protecting against Lassa fever

Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Geneva Foundation, have developed a promising new vaccine candidate that protects against Lassa fever.

12 Sep 2024

Avian influenza detected in Texas wastewater samples

Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas cities by researchers at UTHealth Houston and Baylor College of Medicine.

12 Sep 2024

Genetics of Alzheimer's disease and dementia in African populations presented at Nairobi conference

Regions of the genome associated with Alzheimer's disease and dementia in African populations will be presented at the Future of Dementia in Africa conference on September 11-12, 2024.

12 Sep 2024

Molnupiravir reduces long-term COVID-19 symptoms but shows limited impact on hospitalizations

Molnupiravir treatment for COVID-19 shows modest long-term benefits, reducing symptoms and improving well-being at three and six months. However, the differences were small, with no impact on hospitalization rates.

11 Sep 2024

Expert survey unveils underestimated health impacts of weather and climate on mortality

The study analyzes expert views on climate's role in mortality, linking weather hazards to health outcomes and highlighting urgent preventive strategies.

10 Sep 2024

Chinese farmed fur animals found to harbor dozens of novel viruses

Researchers identified 125 virus species in Chinese farmed fur animals, including 36 novel viruses with significant zoonotic potential, emphasizing the need for enhanced surveillance to prevent future pandemics.

9 Sep 2024

Artificial lymphoid organ-chips created to predict vaccine responses in humans

Researchers at the Institut Pasteur in France have developed artificial "lymphoid organ-chips" that recreate much of the human immune system's response to booster vaccines

6 Sep 2024

Novel monoclonal antibody appears effective at neutralizing numerous SARS-CoV-2 variants

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.

6 Sep 2024

Arthritis medications could reverse COVID lung damage

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of Virginia School of Medicine and Cedars-Sinai suggests.

6 Sep 2024

Mpox inactivated in 60 seconds with Σ-MM™ & patient friendly collection swab

In the wake of the global Mpox outbreak in non-endemic countries in 2022, the medical community has been searching for safer and more efficient ways to transport and test virus samples, especially from patients in areas with limited biological containment facilities.

From Medical Wire 6 Sep 2024

Insilico Medicine partners with Inimmune to advance immunotherapeutic discovery

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico's proprietary generative artificial intelligence (AI) technology to accelerate the discovery and development of next-generation immunotherapeutics.

5 Sep 2024

Bats and birds in Madrid are top carriers of zoonotic pathogens, study reveals

Researchers characterize potential zoonotic pathogens present in fecal samples of urban vertebrate species.

4 Sep 2024

Study aims to find new ways of alleviating the long-term effects of COVID-19

An innovative study for the treatment of post-COVID syndrome (PCS) is starting under the direction of Frankfurt University Hospital’s Department of Infectious Diseases.

4 Sep 2024

Infectious Diseases News and Research

Moderate coffee consumption linked to lower risk of multiple cardiometabolic diseases

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

NIH funds new research to combat emerging viruses

New research network focuses on high-priority viruses

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

Researchers find no evidence of monkeypox infection in pets, despite presence of viral DNA

COVID-19 vaccines prevented millions of deaths across Latin America and the Caribbean, study shows

New vaccine candidate shows promise for protecting against Lassa fever

Avian influenza detected in Texas wastewater samples

Genetics of Alzheimer's disease and dementia in African populations presented at Nairobi conference

Molnupiravir reduces long-term COVID-19 symptoms but shows limited impact on hospitalizations

Expert survey unveils underestimated health impacts of weather and climate on mortality

Chinese farmed fur animals found to harbor dozens of novel viruses

Artificial lymphoid organ-chips created to predict vaccine responses in humans

Novel monoclonal antibody appears effective at neutralizing numerous SARS-CoV-2 variants

Arthritis medications could reverse COVID lung damage

Mpox inactivated in 60 seconds with Σ-MM™ & patient friendly collection swab

Insilico Medicine partners with Inimmune to advance immunotherapeutic discovery

Bats and birds in Madrid are top carriers of zoonotic pathogens, study reveals

Study aims to find new ways of alleviating the long-term effects of COVID-19

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News